Positron emission tomography (pet) radiopharmaceuticals.
Active Awarded Last action
- Contract number
- 36C24226N0388
- Awardee
-
Sofie CO. UEI JV1AHJHGUGG3
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $830,796
Award facts
- Contract value 100% obligated
- $830,796.45 Current and potential, with all options
- Completion date 63% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sterling, VA, USA
Award details come from SAM.gov/FPDS.
About this award
Sofie CO., doing business as IBA Molecular, was awarded a $830,796.45 firm fixed-price delivery order on March 15, 2026, for the supply of Positron Emission Tomography (PET) radiopharmaceuticals to support the Veterans Integrated Service Network 2 (VISN 2). The contract, which carries no set-aside designation, has an ultimate completion date of March 14, 2027, with performance occurring in Sterling, Virginia. The award represents a delivery order under an existing indefinite delivery vehicle, reflecting the Department of Veterans Affairs' established relationship with Sofie CO. as a specialized supplier of diagnostic radiopharmaceuticals for cancer detection and neurological imaging applications across the VA healthcare system.
Sofie CO. is a subsidiary of Sofie Biosciences, Inc., headquartered in Sterling, Virginia, and specializes in the development and manufacturing of molecular diagnostic and therapeutic radiopharmaceuticals. The company maintains an extensive portfolio of federal contracts with the Department of Veterans Affairs and Defense Health Agency, supplying critical products including PYLARIFY (piflufolastat F-18) for prostate cancer detection, NEURACEQ (florbetaben F-18) for Alzheimer's disease imaging, F-18 fluorodeoxyglucose (FDG) for oncology applications, and various gallium-68 radiopharmaceuticals. The company holds multiple master indefinite delivery contracts and blanket purchase agreements with federal agencies, including a $1.93 million IDV with VISN 2 awarded in April 2025, establishing long-term procurement relationships that enable streamlined supply of essential radiopharmaceuticals to VA medical centers nationwide.
Quick answers
Who was awarded contract 36C24226N0388?
36C24226N0388 was awarded to Sofie CO. by Veterans Integrated Service Network 2 (Veterans Health Administration) on March 15, 2026.
How much is contract 36C24226N0388 worth?
The government has obligated $830,796 on 36C24226N0388.
Is contract 36C24226N0388 an order under another contract?
Yes. 36C24226N0388 is a delivery order under 36C24226D0040, an indefinite delivery contract.
Was contract 36C24226N0388 competed?
The extent of competition for 36C24226N0388 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award